Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
University of California, San Francisco
University of California, San Francisco
Institut du Cancer de Montpellier - Val d'Aurelle
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Washington University School of Medicine
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Kestrel Therapeutics, Inc.
Nuvance Health
Nuvance Health
Nuvance Health
City of Hope Medical Center
NRG Oncology
Abramson Cancer Center at Penn Medicine
University of California, San Diego
University of Massachusetts, Worcester
Columbia University
GCS Ramsay Santé pour l'Enseignement et la Recherche
H. Lee Moffitt Cancer Center and Research Institute
UNC Lineberger Comprehensive Cancer Center
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Centre Leon Berard
Ruijin Hospital
Memorial Sloan Kettering Cancer Center
Imperial College London
Imperial College London
Imperial College London
Ohio State University Comprehensive Cancer Center
University Hospital Southampton NHS Foundation Trust
OHSU Knight Cancer Institute
Chinese University of Hong Kong
Methodist Health System
Institut Paoli-Calmettes
UNC Lineberger Comprehensive Cancer Center
Dana-Farber Cancer Institute
Minia University
University of Virginia
Mayo Clinic
Mayo Clinic
Zhejiang University
Mayo Clinic
Northwell Health
Vanderbilt University Medical Center
University Health Network, Toronto
UMC Utrecht
Medical College of Wisconsin
University of Oklahoma
University of California, Davis
M.D. Anderson Cancer Center
Johns Hopkins University
OHSU Knight Cancer Institute